Seogsong相关文献与解析，生知库 | 链接生命科学的每一步

Longitudinal changes in cardiorespiratory fitness and risk of depressive and anxiety disorders in a nationwide cohort of 7 million participants

一项针对全国700万参与者的队列研究，探讨了心肺功能纵向变化与抑郁症和焦虑症风险之间的关系。

doi:10.1038/s41598-026-41932-2

Park, Jin-Hyun; Kong, Seokjin; Lim, Yohwan; Oh, Yunhwan; Chawanid, Porwarat; Gökbulut, Batuhan; Kim, Ju-Wan; Park, Sun Jae; Kim, Hye Jun; Cheon, Sangwook; Kang, Eun Seok; Jang, Seohui; Lee, Jeongin; Kang, Minjeong; Kwak, Taeho; Kim, Yihyun; Song, Jihun; Khil, Jaewon; Lee, Su Kyoung; Kim, Jae-Min; Jeong, Seogsong; Lee, Hwamin

Statin use and the risk of liver-related events in older adults with steatotic liver disease

他汀类药物的使用与老年脂肪肝患者发生肝脏相关事件的风险

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-026-43347-5

Kang, Eun Seok; Kim, Hye Jun; Park, Sun Jae; Kang, Ju Hyun; Park, Sangwoo; Sha, Meng; Kang, Seong Hee; Jeong, Seogsong; Park, Sang Min

Lean Metabolic Dysfunction-Associated Steatotic Liver Disease and Dementia Risk: A High-Risk Phenotype beyond Body Mass Index

瘦代谢功能障碍相关脂肪肝和痴呆风险：一种超越体重指数的高风险表型

期刊:Gut and Liver

影响因子:3.2

doi:10.5009/gnl250606

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation

肝细胞癌患者肝移植的标准和预后模型

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0323

Sha, Meng; Wang, Jun; Cao, Jie; Zou, Zhi-Hui; Qu, Xiao-Ye; Xi, Zhi-Feng; Shen, Chuan; Tong, Ying; Zhang, Jian-Jun; Jeong, Seogsong; Xia, Qiang

Correspondence to letter to the editor 2 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study"

致编辑的信函 2，主题为“代谢功能障碍相关脂肪肝疾病的演变及肝细胞癌风险：一项全国性队列研究”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.1175

Jeong, Seogsong; Kim, Won; Park, Sang Min

Correspondence to letter to the editor 1 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study"

致编辑的信函 1，主题为“代谢功能障碍相关脂肪肝疾病的演变及肝细胞癌风险：一项全国性队列研究”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.1171

Jeong, Seogsong; Kim, Won; Park, Sang Min

Erratum to 'Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study' [Clin Mol Hepatol 2024;30:487-499]

对“代谢功能障碍相关脂肪肝疾病的演变变化和肝细胞癌风险：一项全国性队列研究”的勘误[Clin Mol Hepatol 2024;30:487-499]

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2024.0145e

Jeong, Seogsong; Oh, Yun Hwan; Ahn, Joseph C; Choi, Seulggie; Park, Sun Jae; Kim, Hye Jun; Lee, Gyeongsil; Son, Joung Sik; Jang, Heejoon; Lee, Dong Hyeon; Sha, Meng; Chen, Lei; Kim, Won; Park, Sang Min

Pathophysiology, development, and mortality of major non-communicable diseases in metabolic dysfunction-associated steatotic liver disease: A comprehensive review

代谢功能障碍相关脂肪肝疾病中主要非传染性疾病的病理生理学、发展和死亡率：一项综合综述

期刊:International Journal of Biological Sciences

影响因子:10

doi:10.7150/ijbs.117211

Kang, Minjeong; Song, Jihun; Kang, Eun Seok; Jang, Seohui; Kwak, Taeho; Kim, Yihyun; Sha, Meng; Lee, Hwamin; Jeong, Seogsong

Older Age Threshold for Oxaliplatin Benefit in Stage II to III Colorectal Cancer

II期至III期结直肠癌患者接受奥沙利铂治疗获益的年龄阈值较高

期刊:Jama Network Open

影响因子:9.7

doi:10.1001/jamanetworkopen.2025.25660

Bong, Jun Woo; Lee, Hwamin; Jeong, Seogsong; Kang, Sanghee

ADHD and Methylphenidate Use in Prepubertal Children and BMI and Height at Adulthood

青春期前儿童注意力缺陷多动障碍和哌甲酯的使用与成年期体重指数和身高的关系

Longitudinal changes in cardiorespiratory fitness and risk of depressive and anxiety disorders in a nationwide cohort of 7 million participants

一项针对全国700万参与者的队列研究，探讨了心肺功能纵向变化与抑郁症和焦虑症风险之间的关系。

Statin use and the risk of liver-related events in older adults with steatotic liver disease

他汀类药物的使用与老年脂肪肝患者发生肝脏相关事件的风险

Lean Metabolic Dysfunction-Associated Steatotic Liver Disease and Dementia Risk: A High-Risk Phenotype beyond Body Mass Index

瘦代谢功能障碍相关脂肪肝和痴呆风险：一种超越体重指数的高风险表型

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation

肝细胞癌患者肝移植的标准和预后模型

Correspondence to letter to the editor 2 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study"

致编辑的信函 2，主题为“代谢功能障碍相关脂肪肝疾病的演变及肝细胞癌风险：一项全国性队列研究”

Correspondence to letter to the editor 1 on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study"

致编辑的信函 1，主题为“代谢功能障碍相关脂肪肝疾病的演变及肝细胞癌风险：一项全国性队列研究”

Erratum to 'Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study' [Clin Mol Hepatol 2024;30:487-499]

对“代谢功能障碍相关脂肪肝疾病的演变变化和肝细胞癌风险：一项全国性队列研究”的勘误[Clin Mol Hepatol 2024;30:487-499]

Pathophysiology, development, and mortality of major non-communicable diseases in metabolic dysfunction-associated steatotic liver disease: A comprehensive review

代谢功能障碍相关脂肪肝疾病中主要非传染性疾病的病理生理学、发展和死亡率：一项综合综述

Older Age Threshold for Oxaliplatin Benefit in Stage II to III Colorectal Cancer

II期至III期结直肠癌患者接受奥沙利铂治疗获益的年龄阈值较高